Publicacións nas que colabora con Zulaika Grille Cancela (20)

2022

  1. Cancer in patients with heart failure: Incidence, risk factors and prognostic impact

    European Journal of Internal Medicine, Vol. 105, pp. 89-96

2021

  1. Determinants of maximal oxygen uptake in patients with heart failure

    ESC Heart Failure, Vol. 8, Núm. 3, pp. 2002-2008

2020

  1. Association between loop diuretic dose changes and outcomes in chronic heart failure: observations from the ESC-EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1424-1437

  2. Comparison of predicted and observed mortality in patients with heart failure treated at a specialized unit

    Revista Espanola de Cardiologia, Vol. 73, Núm. 8, pp. 652-659

  3. Sex- and age-related differences in the management and outcomes of chronic heart failure: an analysis of patients from the ESC HFA EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 1, pp. 92-102

  4. Unravelling the interplay between hyperkalaemia, renin–angiotensin–aldosterone inhibitor use and clinical outcomes. Data from 9222 chronic heart failure patients of the ESC-HFA-EORP Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 22, Núm. 8, pp. 1378-1389

2019

  1. Acute heart failure congestion and perfusion status – impact of the clinical classification on in-hospital and long-term outcomes; insights from the ESC-EORP-HFA Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1338-1352

  2. Sacubitril/valsartan eligibility and outcomes in the ESC-EORP-HFA Heart Failure Long-Term Registry: bridging between European Medicines Agency/Food and Drug Administration label, the PARADIGM-HF trial, ESC guidelines, and real world

    European Journal of Heart Failure, Vol. 21, Núm. 11, pp. 1383-1397

2018

  1. Performance of Prognostic Risk Scores in Chronic Heart Failure Patients Enrolled in the European Society of Cardiology Heart Failure Long-Term Registry

    JACC: Heart Failure, Vol. 6, Núm. 6, pp. 452-462

2016

  1. Analysis of variants in the HCN4 gene and in three single nucleotide polymorphisms of the CYP3A4 gene for association with ivabradine reduction in heart rate: A preliminary report

    Cardiology Journal, Vol. 23, Núm. 5, pp. 573-582

  2. Utilidad de una herramienta educativa sencilla (4 fichas de colores) y evaluación de la satisfacción de los pacientes

    XX Encuentro Internacional de Investigación en Cuidados

2015

  1. Clinical evaluation of rosuvastatin in heart transplant patients with hypercholesterolemia and therapeutic failure of other statin regimens: Short-term and long-term efficacy and safety results

    Transplant International, Vol. 28, Núm. 9, pp. 1034-1041

  2. Significado pronóstico y evolución a largo plazo de la frecuencia cardiaca en los pacientes con trasplante cardiaco

    Revista Espanola de Cardiologia, Vol. 68, Núm. 11, pp. 943-950

  3. Venous thromboembolism in heart transplant recipients: Incidence, recurrence and predisposing factors

    Journal of Heart and Lung Transplantation, Vol. 34, Núm. 2, pp. 167-174

2013

  1. Are hospitalized or ambulatory patients with heart failure treated in accordance with European Society of Cardiology guidelines? Evidence from 12 440 patients of the ESC Heart Failure Long-Term Registry

    European Journal of Heart Failure, Vol. 15, Núm. 10, pp. 1173-1184

2012

  1. Cumulative incidence of cytomegalovirus infection and disease after heart transplantation in the last decade: Effect of preemptive therapy

    Transplantation Proceedings

  2. Indoleamine, 2-3 dioxygenase activity could be an early marker of graft rejection in heart transplantation

    Transplantation Proceedings

2010

  1. Conversion of heart transplant patients from standard to sustained-release tacrolimus requires a dosage increase

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2994-2996

  2. Efficacy and tolerance of different types of prophylaxis for prevention of early aspergillosis after heart transplantation

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 3014-3016

  3. Prevalence of donor-transmitted coronary artery disease and its influence on heart transplant outcomes

    Transplantation Proceedings, Vol. 42, Núm. 8, pp. 2987-2991